The Impact of Exercise on Cardiotoxicity in Pediatric and Adolescent Cancer Survivors: A Scoping Review

Childhood and adolescent cancer survivors are disproportionately more likely to develop cardiovascular diseases from the late effects of cardiotoxic therapies (e.g., anthracycline-based chemotherapy and chest-directed radiotherapy). Currently, dexrazoxane is the only approved drug for preventing can...

Descripción completa

Detalles Bibliográficos
Autores principales: Kendall, Stephanie J., Langley, Jodi E., Aghdam, Mohsen, Crooks, Bruce N., Giacomantonio, Nicholas, Heinze-Milne, Stefan, Johnston, Will J., Keats, Melanie R., Mulvagh, Sharon L., Grandy, Scott A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497997/
https://www.ncbi.nlm.nih.gov/pubmed/36135069
http://dx.doi.org/10.3390/curroncol29090500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497997/
https://www.ncbi.nlm.nih.gov/pubmed/36135069
http://dx.doi.org/10.3390/curroncol29090500

Ejemplares similares